Memos and Alerts
UKMi Q&A via SPS – New Resources
UKMi publish a series of Q&A documents on the NHS SPS website, with summaries of high quality, evidence-based, and quality controlled […]
SPS Resources – UKMi Q&A documents
The UK Medicines Infomation network publish a series of Question & Answer documents via the NHS Specialist Pharmacy Service website. […]
Aldosterone Antagonist Monitoring: Room for Improvement in UK Primary Care
NICE recommend offering or considering the addition of an aldosterone antagonist (AA), such as spironolactone and eplerenone, to treatment with an angiotensin-converting […]
Antibiotic Allergy – Mislabelling Contributes to Resistance
The Lancet has published a global update on antibiotic allergy epidemiology, classification, mechanisms, and management – highlighting the public health importance […]
COPD – New NICE Guidance
NICE has published updated guidance on Diagnosis & Management of COPD, with new recommendations on: incidental findings on chest X‑rays […]
Problematic Polypharmacy – Health Secretary Initiative
The Secretary of State for Health & Social Care, Matt Hancock, has asked the Chief Pharmaceutical Officer, Keith Ridge, to […]
Adalat – Supply Issues
Bayer have announced plans to permanently discontinue nifedipine immediate-release 5mg & 10mg capsules (Adalat) in 2019. There are no other […]
Bricanyl Turbohaler – UK Shortage
Bricanyl Turbohaler is the ONLY terbutaline inhaler marketed in the UK. Astra Zeneca UK Ltd have notified the Department of […]
NICE Key Therapeutic Topics 2019 – Consultation Result
NICE have published the results of a consultation on proposals to update the Key Therapeutic Topics collection of resources in 2019 […]